Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease

Journal of the American Society of Nephrology

Volumn 7, Issue 5, 1996, Pages 728-736

  Foley, Robert N ^a   Parfrey, Patrick S ^a   Harnett, John D ^a   Kent, Gloria M ^a   Murray, David C ^b   Barre, Paul E ^c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Grace General Hospital   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Cardiac; ESRD; Hypoalbuminemia; Morbidity; Mortality

Indexed keywords

ALBUMIN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEMODIALYSIS; HUMAN; HYPOALBUMINEMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030357296     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. NIDDKD. US Renal Data System 1994 Annual Report. Bethesda, MD: The National Institute of Diabetes and Digestive and Kidney Diseases; 1994.
2. NIDDKD. US Renal Data System 1992 Annual Report. IV. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 1992;20(Suppl 2):32-38.
3. Raine AE, Margreiter R, Brunner FP, et al.: Combined report on regular dialysis and transplantation in Europe, XXII. Nephrol Dial Transplant 1992;7(Suppl 2):7-35.
4. Hutchinson TA, Thomas CD, MacGibbon B: Predicting survival in adults with end-stage renal failure: An age-equivalence index. Ann Intern Med 1982;22:153-158.
5. Churchill DN, Taylor DW, Cook RJ, et al.: Canadian hemodialysis morbidity study. Am J Kidney Dis 1992;19: 214-234.
6. Foley RN, Parfrey PS, Hefferton D, Singh I, Simms A, Barrett BJ: Advance prediction of early death in patients starting maintenance dialysis. Am J Kidney Dis 1994;23: 836-845.
7. Acchiardo SR, Moore LW, La Tour PA: Malnutrition as the main factor in the morbidity and mortality of hemodialysis patients. Kidney Int 1983;24(Suppl 16):199-203.
8. Owen SR, Lew NL, Yan Liu SM, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-1006.
9. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993;44:115-119.
10. Spiegel DM, Breyer JA: Serum albumin: A predictor of long-term outcome in peritoneal dialysis patients. Am J Kidney Dis 1994;23:283-285.
11. Held PJ, Levin NW, Bovbjerg RR, et al.: Mortality and duration of hemodialysis treatment. JAMA 1991;265: 871-875.
12. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994;23:272-282.
13. Gotch F, Sargent J: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 1985;28: 526-534.
14. Charra B, Calemard E, Ruffet M, et al.: Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-1291.
15. Parker TF, Husni L, Huang W, et al.: Survival of hemodialysis in the U.S. is improved with a greater quantity of dialysis. Am J Kidney Dis 1994;23:670-680.
16. Young GA, Kopple JD, Lindholm B, et al.: Nutritional assessment of continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1991;17:462-471.
17. Cano N, Fernandez JP, Lacombe P, et al.: Statistical selection of nutritional parameters in hemodialysed patients. Proceedings of the Fourth International Congress on Nutrition and Metabolism in Renal Disease. Kidney Int 1987;32:S178-S180.
18. Young GA, Swanepoel CR, Croft MR, Hobson SM, Parsons FM: Anthropometry and plasma valine, amino acids and protein in the nutritional assessment of hemodialysis patients. Kidney Int 1982;21:492-499.
19. Kopple JD: Effect of malnutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 1994;24:1002-1009.
20. Foley RN, Parfrey PS, Harnett JD, et al.: Clinical and echocardiographic disease in end-stage renal disease: Prevalence, associations and prognosis. Kidney Int 1995;47:186-192.
21. Harnett JD, Foley RN, Parfrey PS, Kent GM, Murray DC, Barre PE: Congestive heart failure in dialysis patients: prevalence, incidence, risk factors and prognosis. Kidney Int 1995;47:884-890.
22. Devereux RB, Alonso DR, Lutas EM, et al.: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57: 450-458.
23. Pombo JF, Troy BL, Russell RO Jr: Left ventricular volumes and ejection fractions by echocardiography. Circulation 1971;43:480-490.
24. Levy D, Savage DD, Garrison RJ, et al.: Echocardiographic criteria for left ventricular hypertrophy: The Framingham Study. Am J Cardiol 1987;59:956-960.
25. Huwez FU, Pringle SD, Macfarlane PW: A new classification of left ventricular geometry based on M-mode echocardiography. Am J Cardiol 1992;70:681-688.
26. Dixon WJ, Brown MB, Engelman L, et al., Eds. BMDP Statistical Software Manual. Berkeley: University of California Press; 1985.
27. Kabfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: Wiley; 1980.
28. Keane WF, Collins AJ: Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994;24:1010-1018.
29. Kario K, Matsuo T, Kobaysahi H: Heparin cofactor II deficiency in the elderly: Comparison with antithrombin III. Thromb Res 1992;66:489-498.
30. Toto RD, Lena Vega GL, Grundy SM: Mechanisms and treatment of dyslipidemia of renal diseases. Curr Opin Nephrol Hypertens 1993;2:784-790.
31. Murphy BG, McNamee P, Duly E, et al.: Increased serum apolipoprotein(a) in patients with chronic renal failure treated with continuous ambulatory peritoneal dialysis. Atherosclerosis 1992;93:53-57.
32. Hirata K, Kikuchi S, Saku K, et al.: Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in hemodialysis patients with/without diabetes mellitus. Kidney Int 1993;44:1062-1070.
33. Okura Y, Saku K, Hirata K, et al.: Serum lipoprotein(a) levels in maintenance hemodialysis patients. Nephron 1993;65:46-50.
34. Auguet T, Senti M, Rubies-Prat J, et al.: Serum lipoprotein(a) concentrations in patients with chronic renal failure receiving hemodialysis: Influence of apolipoprotein(a) genetic polymorphism. Nephrol Dial Transplant 1993;8:1099-1103.
35. Webb AT, Reaveley DA, O'Donnell M, et al.: Lipoprotein(a) in patients on maintenance hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993;8:609-613.
36. Thillet J, Faucher C, Issad B, et al.: Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993;22:226-232.
37. Weintraub M, Burstein A, Rassin T, et al.: Severe defect in clearing postprandial chylomicron remnants in dialysis patients. Kidney Int 1992;42:1247-1252.
38. Joven J, Vilella E, Ahmed S, et al.: Lipoprotein heterogeneity in end stage renal disease. Kidney Int 1992;42: 1247-1252.
39. Maggi E, Bellazzi R, Falaschi F, et al.: Enhanced LDL oxidation in uremic patients. An additional mechanism for accelerated atherosclerosis? Kidney Int 1994;45: 876-883.
40. Reade V, Tailleaux A, Reade R, et al.: Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients. Kidney Int 1993;44:1360-1365.
41. Tschope W, Koch M, Thomas B, Ritz E: Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia. Nephron 1993;64:354-358.
42. Tschope W, Koch M, Thomas B, Ritz E: Survival and predictors of death in dialysed diabetic patients. Diabetologia 1993;36:1113-1117.
43. Cressman MD, Heyka RJ, Paganini EP, et al.: Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992;86: 475-482.
44. Goldwasser P, Michel MA, Collier MA, et al.: Prealbumin and lipoprotein(a) in hemodialysis: Relationship with patients and vascular access survival. Am J Kidney Dis 1993;22:215-225.
45. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697.
46. Shapiro J. Atherogenesis in chronic renal failure. In: Parfrey PS, Harnett JD, Eds. Cardiac Dysfunction in Chronic Uremia. Boston: Kluwer Academic Press; 1992: 187-204.
47. Gris J-C, Branger B, Vecina F, et al.: Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 1994;46:807-813.
48. Haaber AB, Eidemak I, Jensen T, Feldt-Rasmussen B, Strandgaard S: Vascular endothelial function and cardiovascular risk factors in patients with chronic renal failure. J Am Soc Nephrol 1995;5:1581-1584.
49. Alexander RW: Inflammation and coronary artery disease. N Engl J Med 1994;331:468-469.
50. Saikku P, Leinnonen M, Tenkanen L, et al.: Chlamydia pneumonia infection as a risk factor for coronary artery disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-278.
51. Mendall MA, Goggin PM, Molineaux N, et al.: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-439.
52. Hendrix MG, Salimans MM, van Boven CP, et al.: : High prevalence of latently present CMV in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990;136:23-28.
53. Hakim RM, Stannard D, Port F, Held P: The effect of the dialysis membrane on mortality of chronic hemodialysis patients in the U.S. [Abstract.] J Am Soc Nephrol 1994; 5:451A.
54. Stampfer MJ, Malinow MR, Willett WC, et al.: A prospective study of homocyst(e)ine and risk of myocardial infarction in U.S. physicians. JAMA 1992;268:877.
55. Chaveau P, Chadefaux B, Coude B, et al.: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993;44:881-886.
56. Chauveau P, Chadefaux B, Coude M, et al.: Increased plasma homocysteine concentrations in patients with chronic renal failure. Miner Electrolyte Metab 1992;18: 196.
57. Selhun J, Jacques PF, Wilson PWF, et al.: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270: 2693.
58. Follis RH. Deficiency Disease: Functional and Structural Changes in Mammals, Which Result From Exogenous or Endogenous Lack of One or More Essential Nutrients. Springfield, IL: Charles C Thomas; 1958.
59. Smythe PM, Swanepoel A, Campbell JAH: The heart and kwashiorkor. Br Med J 1962;1:67-73.
60. Wharton BA, Balmer SE, Somers K, et al.: The myocardium in kwashiorkor. Q J Med 1969;38:107-116.
61. Wharton BA, Howells GR, McGance RA: Cardiac failure in kwashiorkor. Lancet 1967;2:384-387.
62. Piza J, Troper L, Cespedes R, et al.: Myocardial lesions and heart failure in infantile malnutrition. Am J Trop Med Hyg 1971;20:343-355.
63. Rostand SG, Kirk KA, Rutsky EA: Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int 1984;25:653-659.